Wellington Management Group’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-39,645
Closed -$431K 1992
2024
Q2
$431K Sell
39,645
-4,712,552
-99% -$51.2M ﹤0.01% 1783
2024
Q1
$89.1M Sell
4,752,197
-1,309,799
-22% -$24.5M 0.02% 585
2023
Q4
$131M Sell
6,061,996
-510,264
-8% -$11.1M 0.02% 500
2023
Q3
$135M Buy
6,572,260
+208,630
+3% +$4.29M 0.03% 450
2023
Q2
$299M Buy
6,363,630
+649,207
+11% +$30.5M 0.06% 305
2023
Q1
$240M Buy
5,714,423
+198,287
+4% +$8.32M 0.05% 351
2022
Q4
$210M Buy
5,516,136
+583,618
+12% +$22.3M 0.04% 375
2022
Q3
$193M Buy
4,932,518
+182,895
+4% +$7.16M 0.04% 376
2022
Q2
$153M Sell
4,749,623
-2,245,377
-32% -$72.5M 0.03% 440
2022
Q1
$232M Sell
6,995,000
-131,411
-2% -$4.35M 0.04% 381
2021
Q4
$303M Buy
7,126,411
+356,478
+5% +$15.2M 0.05% 339
2021
Q3
$300M Buy
6,769,933
+957,993
+16% +$42.4M 0.05% 345
2021
Q2
$330M Buy
5,811,940
+646,151
+13% +$36.7M 0.06% 317
2021
Q1
$387M Buy
5,165,789
+882,160
+21% +$66M 0.07% 281
2020
Q4
$371M Buy
4,283,629
+4,045,121
+1,696% +$350M 0.07% 269
2020
Q3
$14.6M Buy
238,508
+94,161
+65% +$5.76M ﹤0.01% 1017
2020
Q2
$6M Buy
+144,347
New +$6M ﹤0.01% 1178
2020
Q1
Sell
-975,613
Closed -$70.4M 2024
2019
Q4
$70.4M Sell
975,613
-1,013,614
-51% -$73.2M 0.01% 670
2019
Q3
$279M Sell
1,989,227
-200,445
-9% -$28.1M 0.06% 293
2019
Q2
$401M Sell
2,189,672
-17,689
-0.8% -$3.24M 0.09% 233
2019
Q1
$351M Buy
2,207,361
+285,526
+15% +$45.4M 0.08% 246
2018
Q4
$184M Sell
1,921,835
-48,935
-2% -$4.69M 0.05% 359
2018
Q3
$278M Sell
1,970,770
-10,734
-0.5% -$1.52M 0.06% 314
2018
Q2
$310M Sell
1,981,504
-287,018
-13% -$44.9M 0.07% 287
2018
Q1
$365M Buy
2,268,522
+199,517
+10% +$32.1M 0.08% 252
2017
Q4
$341M Buy
2,069,005
+369,796
+22% +$60.9M 0.08% 256
2017
Q3
$106M Buy
1,699,209
+114,760
+7% +$7.15M 0.02% 530
2017
Q2
$126M Buy
+1,584,449
New +$126M 0.03% 446